Skip to main content
CVS logo

CVS · CVS HEALTH Corp · Metrics

Track CVS — free
Market Cap
$109.79B
Shares
1.28B
Volume · Nov 18 5.29M Avg daily vol (3M) 9.11M

CVS metrics

117 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$85.81
Market cap
$109.79B

Price action

23 metrics
Price change (1W)
-3.6%
Price change (30D)
-7.4%
Price change (3M)
-9.6%
Price change (6M)
-8.9%
Price change (YTD)
+8.1%
Price change (1Y)
+9.4%
Trailing year
Price change (5Y)
-7.5%
52-week high
$110.60
52-week low
$70.08
Change from 52-week high
-22.4%
Change from 52-week low
+22.4%
Annualized volatility
34.2%
Annualized volatility (3M)
36.5%
Implied volatility (30D)
31.7%
IV rank (1Y)
36.6
IV percentile (1Y)
51.8
Beta
0.0
RSI (14D)
43.6
Price vs SMA 50
-3.9%
Price vs SMA 200
-3.9%
Avg volume (3M)
9.11M
Relative volume
1.5
Average dollar volume
$811.96M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
1.28B

Valuation

12 metrics
P / E (TTM)
10.0
Trailing earnings · reciprocal yield 10.0%
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 270.3%
EV / EBITDA
7.9×
reciprocal yield 12.6%
EV / EBIT
10.3×
reciprocal yield 9.7%
P / sales
0.3×
reciprocal yield 383.1%
P / book
1.4
reciprocal yield 73.3%
FCF yield
14.2%
TTM · current market cap
Buyback yield
0.0%
P / FCF
7.1
reciprocal yield 14.2%
P / operating cash flow
5.9
reciprocal yield 17.0%
Earnings yield
10.1%

Historical valuation

8 metrics
P / E historical average (3Y)
36.5×
reciprocal yield 2.7%
P / E historical average (5Y)
31.4×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
0.4×
reciprocal yield 269.1%
EV / revenue historical average (5Y)
0.4×
reciprocal yield 237.5%
EV / EBIT historical average (3Y)
17.7×
reciprocal yield 5.7%
EV / EBIT historical average (5Y)
17.3×
reciprocal yield 5.8%
EV / EBITDA historical average (3Y)
10.9×
reciprocal yield 9.1%
EV / EBITDA historical average (5Y)
11.1×
reciprocal yield 9.0%

Dividends & buybacks

7 metrics
Dividend yield
3.1%
Trailing 12 months
Payout ratio
31.0%
Shareholder yield
—
Dividend / share (TTM)
$2.66
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-10-22

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-04

Profitability

9 metrics
Gross margin
44.2%
Operating margin
3.6%
Trailing 12 months
Net margin
2.6%
Gross profit (TTM)
$186.06B
Operating profit (TTM)
$15.06B
Net income (TTM)
$11.04B
Trailing 12 months
Diluted EPS (TTM)
$8.60
FCF margin
3.7%
Effective tax rate
8.8%

Per share

11 metrics
Revenue per diluted share (TTM)
$327.44
Gross profit per diluted share (TTM)
$144.85
Operating profit per diluted share (TTM)
$11.72
EBITDA per diluted share (TTM)
$15.24
Net income per diluted share (TTM)
$8.60
Operating cash flow per diluted share (TTM)
$14.56
Free cash flow per diluted share (TTM)
$12.11
Capital expenditures per diluted share (TTM)
$2.45
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.58
Book value per share
$59.18

Growth

11 metrics
Revenue growth YoY
+5.4%
Year over year
Net income growth YoY
-61.7%
Revenue (TTM)
$420.61B
Trailing 12 months
EPS growth YoY
-62.0%
Shares change YoY
+1.7%
Year over year · more shares
Revenue CAGR (3Y)
+7.6%
Revenue CAGR (5Y)
+8.4%
EPS CAGR (3Y)
-24.7%
EPS CAGR (5Y)
-23.9%
FCF CAGR (3Y)
-16.6%
FCF CAGR (5Y)
-10.3%

Quality

14 metrics
Return on equity
13.7%
Return on assets
4.3%
Debt / equity
0.8
Current ratio
0.9
EBITDA (TTM)
$19.58B
Free cash flow (TTM)
$15.57B
Quick ratio
0.7
Interest coverage
4.9
Net debt / EBITDA
2.3
Return on invested capital
10.9%
Trailing 12 months
Net cash
−$45.79B
Latest balance sheet
Cash & equivalents
$11.74B
Total assets
$258.07B
Total debt
$60.68B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$18.71B
Capital expenditures (TTM)
$3.14B
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$745.00M
R&D / revenue
—
Stock compensation / revenue
0.2%

Ownership (13F)

9 metrics
13F filers
1,987
13F filer change QoQ
-103
Institutional ownership
86.7%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
15.4%
Private-fund adviser ownership
15.0%
Active holders' share change QoQ
-1.4%
Holder tenure
20.0
Price vs estimated holder cost
+8.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.6%

Short interest

3 metrics
Short interest
1.4%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
54 / 100

Insider activity

2 metrics
Net insider buying (90D)
$2.00M
Insider-sentiment score
80 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 64803 CUSIP 126650100 13F (30d) 1823 filings 1708 filers Visit website Investor relations